Michael Bernhard

Michael Bernhard Email and Phone Number

CEO at Bernhard Associates Inc. @
Michael Bernhard's Location
Summit, New Jersey, United States, United States
Michael Bernhard's Contact Details
About Michael Bernhard

Experienced in regulatory affairs and product development for drugs, biologics and medical devices (Rx, Rx to OTC, OTC, ANDA, 510(k)). Experienced in small and large companies, including start-ups and large companies such as Schering Plough, Becton Dickinson and Block Drug. Extensive negotiations with all divisons at FDA, including DDMAC. Can help clients in CMC, clinical, strategy, FDA meetings, inspections, line extensions, due diligence. Over 19 new NDAs, 24 INDs, 6 CTAs, ANDAs, 510(k)s; many FDA meetings, 5 US patents, etc. Now retired.Specialties: Regulatory affairs expert and product development experience in drugs, biologics, medical devices, including NDAs, BLAs, CTAs, 510ks, advertising and promotion. CMC, clinical, FDA negotiations and meetings, regulatory strategy, product development strategy. Conducted expert reviews for 2 EU marketing applications, expert witness.

Michael Bernhard's Current Company Details
Bernhard Associates Inc.

Bernhard Associates Inc.

CEO at Bernhard Associates Inc.
Michael Bernhard Work Experience Details
  • Bernhard Associates Inc.
    Ceo
    Bernhard Associates Inc. Jan 1996 - Present
    Pharmaceutical and medicval device consulting. Currently preparing 2 monoclonal antibody INDs for oncology indications. Prepared expert reviews for 2 Johnson & Johnson company EU marketing applications, etc.
  • Glenmark Therapeutics, Inc
    Vp, Global Regulatory Affairs
    Glenmark Therapeutics, Inc Dec 2007 - Dec 2008
    Mumbai, Maharashtra, In
    Built global regulatory affairs department for this new drug (NME) division of a successful Indian generic pharmaceutical company until funding forced closing US office. Worked closely with associates in India, Switzerland and the UK. Member of Operating Committee, member of due dilligence group. Filed US, EU and Indian INDs/CTAs for monoclonal antibody for RA and small molecules for RA, diabetes, etc.
  • Medpointe Pharmaceuticals
    Senior Director And Head, Regulatory Affairs
    Medpointe Pharmaceuticals Mar 2005 - Dec 2007
    Us
    Specialty pharmaceutical company, vertically integrated, now Meda Pharmaceuticals. Filed several new NDAs and INDs, numerous NDA supplements for line extensions to extend product life. Conducted numerous FDA meetings, including several successful (and one unsuccessful) dispute resolution meetings. Numerous interactions with DDMAC, DTC advertising negotiations with DDMAC, etc.
  • Ferring Pharmaceuticals
    Head, Us Regulatory Affairs And Qa
    Ferring Pharmaceuticals Mar 1999 - Mar 2005
    St-Prex, Ch
    Prepared and filed 6 successful NDAs, most for fertility products, 2 device 510(k)s and 3 INDs. Conducted many FDA meetings, many negotiations with DDMAC. Worked closely with associates in Sweden and Denmark, manufacturing plants in these countries and contract manufacturers in the US. Responsible for release of all commercial and clinical drug batches, conduct of contractor audits, etc.
  • Fei Technologies Inc
    Cso And Vp, Pharmaceutical Development
    Fei Technologies Inc Mar 1998 - Mar 1999
    Developed several new sustained release silicone based drug delivery products. Left when company was sold.
  • Becton Dickinson Transdermal Systems
    Director, R&D
    Becton Dickinson Transdermal Systems Mar 1995 - Mar 1998
    Responsible for developement of iontophoretic transdermal patches, including design, manufacture and oversight of clinical trials. Conducted 4 first in man phase 1 studies with partner companies (in the US and UK), developed several new patches, 5 US and international patents. Supervised over 25 professionals and designed manufacturing facility.
  • Block Drug Company, Reed & Carnrick
    Vp, Worldwide Product Development
    Block Drug Company, Reed & Carnrick Aug 1990 - Mar 1995
    Started as Director, Regulatory Affairs and then promoted to VP, Worldwide Product Development. First new NDA in 10 years; developed numerous new OTC products, first NCEs in 20 years (Rx productss) FDA meetings and inspections, etc.
  • Schering Plough
    Director, Regulatory Affairs
    Schering Plough Aug 1983 - Aug 1990
    Initially director of biologics research and biologics regulatory affairs at Key Pharmaceuticals and transferred to Schering-Plough after Schering purchased Key. At Schering, director of regulatory affairs for 1/3 of Schering products, including allergy/asthma, dermatologicals, some biologicals, all line extensions, all Rx-to-OTC switches. Responsible for all aspects of these product areas.
  • Coulter Immunology
    Assistant General Manager
    Coulter Immunology Aug 1982 - Aug 1983
    Developed monoclonal antibodies for tumor associated antiogens and for blood cell typings for FACS analysis; assisted in development of EPICS (FACS) machines.
  • National Cancer Institute
    Acting Section Chief, Monoclonal Antibody Section
    National Cancer Institute Aug 1980 - Jul 1982
    Second scientist in Biological Response Modifiers Program. Established, staffed and directed largest monoclonal antibody lab in NIH. Developed tumor-associated monoclonal antibodies. Developed first monoclonal antibodies to solid tumors to locate (via radiolabel) and treat (by conjugation with ricin toxin) solid tumors in animal models preparatory to human trials. Left when appointment expired.
  • University Of Virginia Medical School
    Assistant Professor And Head, Breast Cancer Research Lab
    University Of Virginia Medical School Aug 1978 - Aug 1980
    Taught courses in immunology and oncology in the medical school and established and ran the University's first Breast Cancer Research Laboratory; obtained NCI grant.

Michael Bernhard Skills

Regulatory Affairs Fda Clinical Trials Oncology Pharmaceutical Industry Quality Assurance Clinical Research Ind Strategy Biotechnology R&d Drug Development Clinical Development Ctas Regulatory Submissions Gmp Drug Delivery U.s. Food And Drug Administration Biologics Product Development Technology Transfer Validation Immunology Diabetes Sop Research And Development Non Disclosure Agreements Negotiation

Michael Bernhard Education Details

  • Harvard University
    Harvard University
    Business
  • Cornell University
    Cornell University
    Biochemistry Virology
  • Wheatley
    Wheatley
    Hs
  • New York University
    New York University
    Transplantion Immunolgy
  • Tufts University
    Tufts University
    Medical Sciences

Frequently Asked Questions about Michael Bernhard

What company does Michael Bernhard work for?

Michael Bernhard works for Bernhard Associates Inc.

What is Michael Bernhard's role at the current company?

Michael Bernhard's current role is CEO at Bernhard Associates Inc..

What is Michael Bernhard's email address?

Michael Bernhard's email address is mi****@****ink.net

What is Michael Bernhard's direct phone number?

Michael Bernhard's direct phone number is +157067*****

What schools did Michael Bernhard attend?

Michael Bernhard attended Harvard University, Cornell University, Wheatley, New York University, Tufts University.

What are some of Michael Bernhard's interests?

Michael Bernhard has interest in Auto Races, Hiking, Canoeing And Kayaking, Arts.

What skills is Michael Bernhard known for?

Michael Bernhard has skills like Regulatory Affairs, Fda, Clinical Trials, Oncology, Pharmaceutical Industry, Quality Assurance, Clinical Research, Ind, Strategy, Biotechnology, R&d, Drug Development.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.